Trials / Active Not Recruiting
Active Not RecruitingNCT06527846
Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease
Post Marketing Surveillance on Long Term Use of JARDIANCE® Tablets in Patients With Chronic Kidney Disease in Japan
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,024 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Study objective is to investigate the safety and effectiveness of long-term daily use of JARDIANCE® Tablets in patients with chronic kidney disease under real-world use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JARDIANCE® | JARDIANCE® |
Timeline
- Start date
- 2024-10-22
- Primary completion
- 2027-03-31
- Completion
- 2027-03-31
- First posted
- 2024-07-30
- Last updated
- 2026-03-19
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06527846. Inclusion in this directory is not an endorsement.